Specific code 2011 ICD-9-CM Diagnosis Code 193
Malignant neoplasm of thyroid gland
  • Short description: Malign neopl thyroid.
  • ICD-9-CM 193 will be replaced by an equivalent ICD-10-CM code (or codes) when the United States transitions from ICD-9-CM to ICD-10-CM on October 1, 2015.
  • ICD-9-CM 193 is a billable medical code that can be used to specify a diagnosis on a reimbursement claim.
  • You are viewing the 2011 version of ICD-9-CM 193.
  • More recent version(s) of ICD-9-CM 193: 2012 2013 2014.
Disease Synonyms
  • Anaplastic thyroid carcinoma
  • CA of thyroid
  • CA thyroid, papillary
  • Cancer metastatic to lymph node from thyroid
  • Cancer of the thyroglossal duct
  • Cancer of the thyroid
  • Cancer of the thyroid, anaplastic
  • Cancer of the thyroid, follicular
  • Cancer of the thyroid, hurthle cell
  • Cancer of the thyroid, medullary
  • Cancer of the thyroid, papillary
  • Cancer of the thyroid, with metastasis to lungs
  • Follicular carcinoma, thyroid
  • Follicular thyroid carcinoma
  • Hurthle cell carcinoma of thyroid
  • Hurthle cell carcinoma, thyroid
  • Malignant tumor of thyroid gland
  • Medullary carcinoma, thyroid
  • Medullary thyroid carcinoma
  • Papillary carcinoma, thyroid
  • Papillary thyroid carcinoma
  • Primary malignant neoplasm of thyroglossal duct
  • Secondary malignant neoplasm of lungs from thyroid
  • Secondary malignant neoplasm of lymph nodes from thyroid
  • Thyroglossal duct cancer
  • Thyroid cancer
  • Thyroid cancer metastatic to LN
  • Thyroid cancer metastatic to lung
  • Thyroid cancer metastatic to unspecified site
  • Thyroid cancer, anaplastic
Applies To
  • Thyroglossal duct
Use Additional
  • Use additional code to identify any functional activity
Convert to ICD-10-CM: 193 converts directly to:
  • 2014 ICD-10-CM C73 Malignant neoplasm of thyroid gland
ICD-9-CM Volume 2 Index entries containing back-references to 193:
  • Adenocarcinoma (M8140/3) - see also Neoplasm, by site, malignant
    • follicular (M8330/3)
      • and papillary (M8340/3) 193
      • moderately differentiated type (M8332/3) 193
      • pure follicle type (M8331/3) 193
      • specified site - see Neoplasm, by site, malignant
      • trabecular type (M8332/3) 193
      • unspecified type 193
      • well differentiated type (M8331/3) 193
    • Hürthle cell (M8290/3) 193
    • nonencapsulated sclerosing (M8350/3) 193
    • papillary (M8260/3)
      • and follicular (M8340/3) 193
      • intraductal (noninfiltrating) (M8503/2)
        • specified site - see Neoplasm, by site, in situ
        • unspecified site 233.0
      • serous (M8460/3)
        • specified site - see Neoplasm, by site, malignant
        • unspecified site 183.0
  • Carcinoma (M8010/3) - see also Neoplasm, by site, malignant
    • C cell (M8510/3)
      • specified site - see Neoplasm, by site, malignant
      • unspecified site 193
    • follicular (M8330/3)
      • and papillary (mixed) (M8340/3) 193
      • moderately differentiated type (M8332/3) 193
      • pure follicle type (M8331/3) 193
      • specified site - see Neoplasm, by site, malignant
      • trabecular type (M8332/3) 193
      • unspecified site 193
      • well differentiated type (M8331/3) 193
    • Hürthle cell (thyroid) 193
    • medullary (M8510/3)
      • with
        • amyloid stroma (M8511/3)
          • specified site - see Neoplasm, by site, malignant
          • unspecified site 193
        • lymphoid stroma (M8512/3)
          • specified site - see Neoplasm, by site, malignant
          • unspecified site 174.9
    • nonencapsulated sclerosing (M8350/3) 193
    • papillary (M8050/3)
      • and follicular (mixed) (M8340/3) 193
      • epidermoid (M8052/3)
      • intraductal (noninfiltrating) (M8503/2)
        • specified site - see Neoplasm, by site, in situ
        • unspecified site 233.0
      • serous (M8460/3)
        • specified site - see Neoplasm, by site, malignant
        • surface (M8461/3)
          • specified site - see Neoplasm, by site, malignant
          • unspecified site 183.0
        • unspecified site 183.0
      • squamous cell (M8052/3)
      • transitional cell (M8130/3)
    • parafollicular cell (M8510/3)
      • specified site - see Neoplasm, by site, malignant
      • unspecified site 193
    • solid (M8230/3)
      • with amyloid stroma (M8511/3)
        • specified site - see Neoplasm, by site, malignant
        • unspecified site 193
  • Goiter (adolescent) (colloid) (diffuse) (dipping) (due to iodine deficiency) (endemic) (euthyroid) (heart) (hyperplastic) (internal) (intrathoracic) (juvenile) (mixed type) (nonendemic) (parenchymatous) (plunging) (sporadic) (subclavicular) (substernal) 240.9
    • cancerous (M8000/3) 193
    • malignant (M8000/3) 193
  • Hazard-Crile tumor (M8350/3) 193
  • Hürthle cell
    • adenocarcinoma (M8290/3) 193
    • carcinoma (M8290/3) 193
  • Tumor (M8000/1) - see also Neoplasm, by site, unspecified nature
    • hazard-crile (M8350/3) 193
    • Hürthle cell (benign) (M8290/0) 226
      • malignant (M8290/3) 193
    • nonencapsulated sclerosing (M8350/3) 193
  • Wuchernde struma langhans (M8332/3) 193
ICD-9-CM codes are used in medical billing and coding to describe diseases, injuries, symptoms and conditions. ICD-9-CM 193 is one of thousands of ICD-9-CM codes used in healthcare. Although ICD-9-CM and CPT codes are largely numeric, they differ in that CPT codes describe medical procedures and services. Can't find a code? Start at the root of ICD-9-CM, check the 2011 ICD-9-CM Index or use the search engine at the top of this page to lookup any code.